Selected research
Industry Research
Veterinary API Manufacturing Industry Research Report 2026
Market perspective
The global Veterinary API Manufacturing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Veterinary API Manufacturing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Veterinary API Manufacturing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Veterinary API Manufacturing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Veterinary API Manufacturing include Shaanxi Hanjiang Pharmaceutical Group Co., Ltd., Jiangsu Lingyun Pharmaceutical Co., Ltd., SUANFARMA, Ofichem Group, NGL Fine-Chem Ltd., Menadiona, FIS - Fabbrica Italiana Sintetici S.p.A, Excel Industries Ltd. and Alivira Animal Health Ltd. and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Veterinary API Manufacturing market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Veterinary API Manufacturing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Veterinary API Manufacturing Market by Company
Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
Jiangsu Lingyun Pharmaceutical Co., Ltd.
SUANFARMA
Ofichem Group
NGL Fine-Chem Ltd.
Menadiona
FIS - Fabbrica Italiana Sintetici S.p.A
Excel Industries Ltd.
Alivira Animal Health Ltd.
Afton Pharma
Veterinary API Manufacturing Segment by Type
NSAIDs
Anti-infectives
Antiparasitic
Biologics
Vaccines
Others
Veterinary API Manufacturing Segment by Application
In House
Contract Outsourcing
Veterinary API Manufacturing Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary API Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary API Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary API Manufacturing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Veterinary API Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- NSAIDs
- Anti-infectives
- Antiparasitic
- Biologics
- Vaccines
- Others
Applications
- In House
- Contract Outsourcing
Companies covered
- Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
- Jiangsu Lingyun Pharmaceutical Co., Ltd.
- SUANFARMA
- Ofichem Group
- NGL Fine-Chem Ltd.
- Menadiona
- FIS - Fabbrica Italiana Sintetici S.p.A
- Excel Industries Ltd.
- Alivira Animal Health Ltd.
- Afton Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Veterinary API Manufacturing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 NSAIDs
- 2.2.3 Anti-infectives
- 2.2.4 Antiparasitic
- 2.2.5 Biologics
- 2.2.6 Vaccines
- 2.2.7 Others
- 2.3 Veterinary API Manufacturing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 In House
- 2.3.3 Contract Outsourcing
- 2.4 Assumptions and Limitations
3 Veterinary API Manufacturing Breakdown Data by Type
- 3.1 Global Veterinary API Manufacturing Historic Market Size by Type (2021-2026)
- 3.2 Global Veterinary API Manufacturing Forecasted Market Size by Type (2027-2032)
4 Veterinary API Manufacturing Breakdown Data by Application
- 4.1 Global Veterinary API Manufacturing Historic Market Size by Application (2021-2026)
- 4.2 Global Veterinary API Manufacturing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Veterinary API Manufacturing Market Perspective (2021-2032)
- 5.2 Global Veterinary API Manufacturing Growth Trends by Region
- 5.2.1 Global Veterinary API Manufacturing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Veterinary API Manufacturing Historic Market Size by Region (2021-2026)
- 5.2.3 Veterinary API Manufacturing Forecasted Market Size by Region (2027-2032)
- 5.3 Veterinary API Manufacturing Market Dynamics
- 5.3.1 Veterinary API Manufacturing Industry Trends
- 5.3.2 Veterinary API Manufacturing Market Drivers
- 5.3.3 Veterinary API Manufacturing Market Challenges
- 5.3.4 Veterinary API Manufacturing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Veterinary API Manufacturing Players by Revenue
- 6.1.1 Global Top Veterinary API Manufacturing Players by Revenue (2021-2026)
- 6.1.2 Global Veterinary API Manufacturing Revenue Market Share by Players (2021-2026)
- 6.2 Global Veterinary API Manufacturing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Veterinary API Manufacturing Head Office and Area Served
- 6.4 Global Veterinary API Manufacturing Players, Product Type & Application
- 6.5 Global Veterinary API Manufacturing Manufacturers Established Date
- 6.6 Global Veterinary API Manufacturing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Veterinary API Manufacturing Market Size (2021-2032)
- 7.2 North America Veterinary API Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Veterinary API Manufacturing Market Size by Country (2021-2026)
- 7.4 North America Veterinary API Manufacturing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Veterinary API Manufacturing Market Size (2021-2032)
- 8.2 Europe Veterinary API Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Veterinary API Manufacturing Market Size by Country (2021-2026)
- 8.4 Europe Veterinary API Manufacturing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Veterinary API Manufacturing Market Size (2021-2032)
- 9.2 Asia-Pacific Veterinary API Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Veterinary API Manufacturing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Veterinary API Manufacturing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Veterinary API Manufacturing Market Size (2021-2032)
- 10.2 South America Veterinary API Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Veterinary API Manufacturing Market Size by Country (2021-2026)
- 10.4 South America Veterinary API Manufacturing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Veterinary API Manufacturing Market Size (2021-2032)
- 11.2 Middle East & Africa Veterinary API Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Veterinary API Manufacturing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Veterinary API Manufacturing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
- 12.1.1 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Company Information
- 12.1.2 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Business Overview
- 12.1.3 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Revenue in Veterinary API Manufacturing Business (2021-2026)
- 12.1.4 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Veterinary API Manufacturing Product Portfolio
- 12.1.5 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Recent Developments
- 12.2 Jiangsu Lingyun Pharmaceutical Co., Ltd.
- 12.2.1 Jiangsu Lingyun Pharmaceutical Co., Ltd. Company Information
- 12.2.2 Jiangsu Lingyun Pharmaceutical Co., Ltd. Business Overview
- 12.2.3 Jiangsu Lingyun Pharmaceutical Co., Ltd. Revenue in Veterinary API Manufacturing Business (2021-2026)
- 12.2.4 Jiangsu Lingyun Pharmaceutical Co., Ltd. Veterinary API Manufacturing Product Portfolio
- 12.2.5 Jiangsu Lingyun Pharmaceutical Co., Ltd. Recent Developments
- 12.3 SUANFARMA
- 12.3.1 SUANFARMA Company Information
- 12.3.2 SUANFARMA Business Overview
- 12.3.3 SUANFARMA Revenue in Veterinary API Manufacturing Business (2021-2026)
- 12.3.4 SUANFARMA Veterinary API Manufacturing Product Portfolio
- 12.3.5 SUANFARMA Recent Developments
- 12.4 Ofichem Group
- 12.4.1 Ofichem Group Company Information
- 12.4.2 Ofichem Group Business Overview
- 12.4.3 Ofichem Group Revenue in Veterinary API Manufacturing Business (2021-2026)
- 12.4.4 Ofichem Group Veterinary API Manufacturing Product Portfolio
- 12.4.5 Ofichem Group Recent Developments
- 12.5 NGL Fine-Chem Ltd.
- 12.5.1 NGL Fine-Chem Ltd. Company Information
- 12.5.2 NGL Fine-Chem Ltd. Business Overview
- 12.5.3 NGL Fine-Chem Ltd. Revenue in Veterinary API Manufacturing Business (2021-2026)
- 12.5.4 NGL Fine-Chem Ltd. Veterinary API Manufacturing Product Portfolio
- 12.5.5 NGL Fine-Chem Ltd. Recent Developments
- 12.6 Menadiona
- 12.6.1 Menadiona Company Information
- 12.6.2 Menadiona Business Overview
- 12.6.3 Menadiona Revenue in Veterinary API Manufacturing Business (2021-2026)
- 12.6.4 Menadiona Veterinary API Manufacturing Product Portfolio
- 12.6.5 Menadiona Recent Developments
- 12.7 FIS - Fabbrica Italiana Sintetici S.p.A
- 12.7.1 FIS - Fabbrica Italiana Sintetici S.p.A Company Information
- 12.7.2 FIS - Fabbrica Italiana Sintetici S.p.A Business Overview
- 12.7.3 FIS - Fabbrica Italiana Sintetici S.p.A Revenue in Veterinary API Manufacturing Business (2021-2026)
- 12.7.4 FIS - Fabbrica Italiana Sintetici S.p.A Veterinary API Manufacturing Product Portfolio
- 12.7.5 FIS - Fabbrica Italiana Sintetici S.p.A Recent Developments
- 12.8 Excel Industries Ltd.
- 12.8.1 Excel Industries Ltd. Company Information
- 12.8.2 Excel Industries Ltd. Business Overview
- 12.8.3 Excel Industries Ltd. Revenue in Veterinary API Manufacturing Business (2021-2026)
- 12.8.4 Excel Industries Ltd. Veterinary API Manufacturing Product Portfolio
- 12.8.5 Excel Industries Ltd. Recent Developments
- 12.9 Alivira Animal Health Ltd.
- 12.9.1 Alivira Animal Health Ltd. Company Information
- 12.9.2 Alivira Animal Health Ltd. Business Overview
- 12.9.3 Alivira Animal Health Ltd. Revenue in Veterinary API Manufacturing Business (2021-2026)
- 12.9.4 Alivira Animal Health Ltd. Veterinary API Manufacturing Product Portfolio
- 12.9.5 Alivira Animal Health Ltd. Recent Developments
- 12.10 Afton Pharma
- 12.10.1 Afton Pharma Company Information
- 12.10.2 Afton Pharma Business Overview
- 12.10.3 Afton Pharma Revenue in Veterinary API Manufacturing Business (2021-2026)
- 12.10.4 Afton Pharma Veterinary API Manufacturing Product Portfolio
- 12.10.5 Afton Pharma Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst